A former Eli Lilly gross sales rep filed a lawsuit alleging that she was fired after complaining the corporate was selling its Mounjaro diabetes drug to fight weight reduction earlier than receiving regulatory approval to take action.
Jennifer Mansion, who was employed as a senior territory supervisor in Dallas 4 years in the past, claimed that she noticed different Lilly gross sales reps selling the diabetes drug as a salve for weight problems. Mansion additionally contended {that a} doctor touted Mounjaro as a weight reduction possibility throughout a luncheon sponsored by the drugmaker, in response to the go well with filed in federal court docket in Texas.
Such promotions are often called off-label advertising and marketing within the pharmaceutical business. The phrase refers to selling a medication for a utilization that was not authorized by the Meals and Drug Administration. A doctor could prescribe a medication for an unapproved use, however a drugmaker is just not permitted to market its drug for that function.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans
